Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Richard Ross

Concepts (50)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Head and Neck Neoplasms
3
2024
561
0.430
Why?
Receptor, EphB4
1
2024
33
0.210
Why?
Ephrin-B2
1
2024
45
0.210
Why?
Calcitonin Gene-Related Peptide
1
2024
40
0.200
Why?
Cancer Pain
1
2024
39
0.200
Why?
Spiral Cone-Beam Computed Tomography
1
2023
5
0.200
Why?
Bone Neoplasms
1
2024
259
0.180
Why?
Pancreatectomy
1
2024
289
0.170
Why?
Neoadjuvant Therapy
1
2024
465
0.160
Why?
Deoxycytidine
1
2022
220
0.160
Why?
Feasibility Studies
1
2024
1111
0.150
Why?
Graft vs Host Disease
1
2022
279
0.150
Why?
Combined Modality Therapy
1
2022
1266
0.140
Why?
Adenocarcinoma
1
2024
925
0.120
Why?
Hematopoietic Stem Cell Transplantation
1
2022
699
0.120
Why?
Palliative Care
1
2024
1020
0.120
Why?
Pancreatic Neoplasms
1
2024
928
0.110
Why?
Tumor Microenvironment
2
2024
734
0.080
Why?
Radiotherapy, Adjuvant
1
2024
222
0.050
Why?
Cone-Beam Computed Tomography
1
2023
32
0.050
Why?
Chemotherapy, Adjuvant
1
2024
423
0.050
Why?
Epithelial-Mesenchymal Transition
1
2024
219
0.050
Why?
Mice
3
2024
18329
0.050
Why?
Neoplasm Metastasis
1
2024
688
0.040
Why?
Pain Measurement
1
2024
561
0.040
Why?
Humans
6
2024
145474
0.040
Why?
Quality of Life
2
2024
3204
0.040
Why?
Pain Management
1
2024
410
0.040
Why?
Bone Marrow
1
2022
306
0.040
Why?
Transplant Recipients
1
2022
181
0.040
Why?
Survival Rate
1
2024
2090
0.040
Why?
Software
1
2023
680
0.030
Why?
CD8-Positive T-Lymphocytes
1
2024
919
0.030
Why?
CD4-Positive T-Lymphocytes
1
2024
1140
0.030
Why?
Animals
3
2024
38030
0.030
Why?
Cell Line, Tumor
1
2024
3542
0.030
Why?
Prognosis
1
2024
4316
0.030
Why?
Reproducibility of Results
1
2023
3413
0.030
Why?
Follow-Up Studies
1
2024
5423
0.030
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2024
1963
0.030
Why?
Disease Progression
1
2022
2864
0.030
Why?
Aged
2
2024
26153
0.030
Why?
Middle Aged
2
2024
36215
0.020
Why?
Male
3
2024
72842
0.020
Why?
Prospective Studies
1
2024
8057
0.020
Why?
Aged, 80 and over
1
2024
8333
0.020
Why?
Signal Transduction
1
2024
5216
0.020
Why?
Adult
2
2024
40777
0.020
Why?
Female
2
2024
78844
0.010
Why?
Retrospective Studies
1
2024
17291
0.010
Why?
Ross's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)